TNF Pharmaceuticals, Inc. (LON:0A8D)
London flag London · Delayed Price · Currency is GBP · Price in USD
0.0972
+0.0043 (4.57%)
At close: Aug 20, 2025

TNF Pharmaceuticals Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2020
831038168-
Upgrade
Market Cap Growth
-63.16%-75.52%-72.56%-77.64%--
Upgrade
Enterprise Value
10-6432157-
Upgrade
Last Close Price
0.050.916.12---
Upgrade
PB Ratio
0.960.221.033.099.65-
Upgrade
P/TBV Ratio
--7.6311.2017.54-
Upgrade
Debt / Equity Ratio
-0.000.000.010.01-0.79
Upgrade
Quick Ratio
0.691.270.991.7511.120.06
Upgrade
Current Ratio
0.931.401.171.9512.180.06
Upgrade
Return on Equity (ROE)
-115.40%-169.93%-29.12%-79.27%-325.06%-
Upgrade
Return on Assets (ROA)
-24.00%-27.56%-57.77%-45.11%-138.30%-1227.92%
Upgrade
Return on Capital (ROIC)
-87.01%-39.29%-73.94%-49.45%-155.49%-
Upgrade
Earnings Yield
-94.24%-737.28%-30.38%-33.48%-13.10%-
Upgrade
Buyback Yield / Dilution
-239.66%-57.99%-19.18%-10.88%-24.22%25.94%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.